What is Emperra GmbH E-Health Technologies?
Emperra GmbH E-Health Technologies is a research-driven medical technology firm specializing in the intersection of Health IT and telediabetology. Its flagship platform, ESYSTA, serves as a comprehensive digital ecosystem designed to automate the documentation of insulin delivery and blood glucose monitoring. By digitizing these critical metrics, Emperra provides a robust data platform that empowers both patients and healthcare providers to optimize therapy management. The company's market position is defined by its commitment to enhancing diabetes care through seamless, technology-enabled workflows that reduce the administrative burden on medical practices while improving patient outcomes.
How much funding has Emperra GmbH E-Health Technologies raised?
Emperra GmbH E-Health Technologies has raised a total of $6.3M across 2 funding rounds:
Series A
$3.2M
Series B
$3.1M
Series A (2013): $3.2M with participation from GoodVent Beteiligungsmanagement and Charit� Biomedical Fund
Series B (2016): $3.1M led by Robert Bosch Venture Capital GmbH, Peppermint VenturePartners, and Investitionsbank des Landes Brandenburg
Key Investors in Emperra GmbH E-Health Technologies
Robert Bosch Venture Capital GmbH
The corporate venture capital arm of the Bosch Group, focusing on investing in startups that align with the company's strategic interests in IoT, automation, and healthcare technology.
Peppermint VenturePartners
A Berlin-based private venture capital firm specializing in transformative life science companies, providing both funding and operational expertise to foster innovation in the European healthcare sector.
Investitionsbank des Landes Brandenburg
The development bank of the German state of Brandenburg, which provides strategic financing and support to regional enterprises to drive economic growth and technological advancement.
What's next for Emperra GmbH E-Health Technologies?
With the support of its recent capital injection, Emperra is well-positioned to accelerate the integration of its ESYSTA platform into broader healthcare networks. The strategic focus moving forward involves deepening the interoperability of its data systems, allowing for more sophisticated analytics and personalized treatment pathways. As the demand for remote patient monitoring and digital health solutions continues to rise, Emperra is poised to leverage its established technological foundation to capture further market share, potentially expanding its footprint into new international territories and diversifying its portfolio of digital health tools.
See full Emperra GmbH E-Health Technologies company page
